Development and Validation of a Practical Prognostic Coagulation Index for Patients with Esophageal Squamous Cell Cancer

[1]  Jinming Yu,et al.  A nomogram to predict short-term outcome of radiotherapy or chemoradiotherapy based on pre/post-treatment inflammatory biomarkers and their dynamic changes in esophageal squamous cell carcinoma. , 2020, International immunopharmacology.

[2]  W. Renner,et al.  The decreased mean platelet volume is associated with poor prognosis in patients with oropharyngeal cancer treated with radiotherapy , 2020, Radiation oncology.

[3]  E. Nowakowska-Zajdel,et al.  Clinical Characteristics of Colorectal Cancer Patients in terms of Selected Platelet Indices , 2020, Disease markers.

[4]  L. Du,et al.  Development of a Novel Serum Exosomal MicroRNA Nomogram for the Preoperative Prediction of Lymph Node Metastasis in Esophageal Squamous Cell Carcinoma , 2020, Frontiers in Oncology.

[5]  Shaoqing Liu,et al.  Elevated Platelet Count Predicts Poor Prognosis in Breast Cancer Patients with Supraclavicular Lymph Node Metastasis , 2020, Cancer management and research.

[6]  M. Boccadoro,et al.  Clinical Applications and Future Directions of Minimal Residual Disease Testing in Multiple Myeloma , 2020, Frontiers in Oncology.

[7]  Jun Liu,et al.  Identification of a nomogram based on long non-coding RNA to improve prognosis prediction of esophageal squamous cell carcinoma , 2020, Aging.

[8]  Yan Zheng,et al.  Serum Fibrinogen Is An Independent Prognostic Factor In Operable Esophageal Squamous Carcinoma: A Real-World Study , 2019, Cancer management and research.

[9]  C. Sáez,et al.  Coagulation Factor Xa Promotes Solid Tumor Growth, Experimental Metastasis and Endothelial Cell Activation , 2019, Cancers.

[10]  Youxin Wang,et al.  Survival of Esophageal Cancer in China: A Pooled Analysis on Hospital-Based Studies From 2000 to 2018 , 2019, Front. Oncol..

[11]  Jing Zhao,et al.  Decreased mean platelet volume predicts poor prognosis in metastatic colorectal cancer patients treated with first-line chemotherapy: results from mCRC biomarker study , 2019, BMC Cancer.

[12]  S. Navarro,et al.  High Oct4 expression: implications in the pathogenesis of neuroblastic tumours , 2019, BMC Cancer.

[13]  S. Jiao,et al.  A nomogram-based immunoprofile predicts overall survival for previously untreated patients with esophageal squamous cell carcinoma after esophagectomy , 2018, Journal of Immunotherapy for Cancer.

[14]  A. Jemal,et al.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.

[15]  O. Repetto,et al.  Coagulation and fibrinolysis in gastric cancer , 2017, Annals of the New York Academy of Sciences.

[16]  Yun Wang,et al.  Fibrinogen promotes malignant biological tumor behavior involving epithelial–mesenchymal transition via the p-AKT/p-mTOR pathway in esophageal squamous cell carcinoma , 2017, Journal of Cancer Research and Clinical Oncology.

[17]  P. Sen,et al.  Coagulation factor VIIa-mediated protease-activated receptor 2 activation leads to β-catenin accumulation via the AKT/GSK3β pathway and contributes to breast cancer progression , 2017, The Journal of Biological Chemistry.

[18]  Issue Information , 2017 .

[19]  H. Ishwaran,et al.  Cancer of the Esophagus and Esophagogastric Junction: An Eighth Edition Staging Primer , 2017, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[20]  M. Hassali,et al.  Disseminated Intravascular Coagulation and Excessive Fibrinolysis (DIC XFL) Syndrome in Prostate Cancer: A Rare Complicated Disorder. , 2017, Journal of clinical and diagnostic research : JCDR.

[21]  M. Rescigno,et al.  Hypercoagulation and complement: Connected players in tumor development and metastases. , 2016, Seminars in immunology.

[22]  S. Tucker,et al.  Thrombin—unique coagulation system protein with multifaceted impacts on cancer and metastasis , 2016, Cancer and Metastasis Reviews.

[23]  P. Bendahl,et al.  Diverse roles of cell-specific hypoxia-inducible factor 1 in cancer-associated hypercoagulation. , 2016, Blood.

[24]  N. Mackman,et al.  Venous thrombosis and cancer: from mouse models to clinical trials , 2015, Journal of thrombosis and haemostasis : JTH.

[25]  Ying Huang,et al.  A nomogram to predict prognostic values of various inflammatory biomarkers in patients with esophageal squamous cell carcinoma. , 2015, American journal of cancer research.

[26]  C. Seretis,et al.  Hypercoagulation in colorectal cancer: What can platelet indices tell us? , 2015, Platelets.

[27]  J. Ferlay,et al.  Global incidence of oesophageal cancer by histological subtype in 2012 , 2014, Gut.

[28]  C. Holmes,et al.  Platelets, coagulation and fibrinolysis in breast cancer progression , 2013, Breast Cancer Research.

[29]  Robson Q. Monteiro,et al.  Activation of blood coagulation in cancer: implications for tumour progression , 2013, Bioscience reports.

[30]  E W Steyerberg,et al.  Preoperative chemoradiotherapy for esophageal or junctional cancer. , 2012, The New England journal of medicine.

[31]  M. Neurath,et al.  IL-6 signaling in autoimmunity, chronic inflammation and inflammation-associated cancer. , 2011, Cytokine & growth factor reviews.

[32]  Haijun Yu,et al.  MicroRNA-19 (miR-19) Regulates Tissue Factor Expression in Breast Cancer Cells* , 2010, The Journal of Biological Chemistry.

[33]  L. Borsig.  The role of platelet activation in tumor metastasis , 2008, Expert review of anticancer therapy.

[34]  J. Rak,et al.  Tissue factor in cancer and angiogenesis: the molecular link between genetic tumor progression, tumor neovascularization, and cancer coagulopathy. , 2006, Seminars in thrombosis and hemostasis.

[35]  P. Fratino,et al.  Human breast and colon carcinomas express cysteine proteinase activities with pro‐aggregating and pro‐coagulant properties , 1988, International journal of cancer.